Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Urologic Neoplasms × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Prostatic Neoplasms 4 Multiple Myeloma 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Myeloid, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Burkitt Lymphoma 4 Waldenstrom Macroglobulinemia 3 Sezary Syndrome 3 Recurrence 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Mycosis Fungoides 3 Lymphoma, Extranodal NK-T-Cell 3 Leukemia, Hairy Cell 3 Hodgkin Disease 3 Breast Neoplasms 3 Brain Neoplasms 3 Blast Crisis 3 Melanoma 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma 2 Leukemia, Myeloid, Chronic-Phase 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

Gemcitabine 5 Trastuzumab 3 pembrolizumab 2 Pemetrexed 2 Paclitaxel 2 Carboplatin 2 vinflunine 1 niraparib 1 montanide ISA 51 1 flt3 ligand protein 1 enfortumab vedotin 1 cabozantinib 1 atezolizumab 1 abemaciclib 1 Zoledronic Acid 1 Urinary Diversion 1 Therapeutics 1 Thalidomide 1 Sunitinib 1 Radiosurgery 1 MART-1 Antigen 1 Immunoglobulins, Intravenous 1 Immune Checkpoint Inhibitors 1 Drug Therapy 1 Dosage Forms 1 Cystectomy 1 Cisplatin 1 Cetuximab 1 CP protocol 1 Biological Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05038657 2022-10-03

AURORA

University Hospital Southampton NHS Foundation Trust

Phase 2 Unknown

Carcinoma, Squamous Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡